Advertisement

Sepsis pp 17-33 | Cite as

Clinical Aspects of Sepsis: An Overview

  • Giacomo Monti
  • Giovanni LandoniEmail author
  • Daiana Taddeo
  • Francesca Isella
  • Alberto Zangrillo
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1237)

Abstract

Sepsis is one of the oldest and most elusive syndromes in medicine. With the confirmation of germ theory by Semmelweis, Pasteur, and others, sepsis was considered as a systemic infection by a pathogenic organism. Although the germ is probably the beginning of the syndrome and one of the major enemies to be identified and fought, sepsis is something wider and more elusive. In this chapter clinically relevant themes of sepsis will be approached to provide an insight of everyday clinical practice for healthcare workers often not directly involved in the patient’s management.

Key words

Sepsis Severe sepsis Septic shock Sites of infection 

References

  1. 1.
    Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31:1250–1256PubMedCrossRefGoogle Scholar
  2. 2.
    Dellinger RP, Mitchell ML, Andrew R, Djillali A, HerwigGerlach SM, Opal JE et al (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med 41:580–637PubMedCrossRefGoogle Scholar
  3. 3.
    Klein K, Peter MC, David SYO, Marc JMB, Olaf LC (2012) Classification of sepsis, severe sepsis and septic shock: the impact of minor variations in data capture and definition of SIRS criteria. Intensive Care Med 38:811–819CrossRefGoogle Scholar
  4. 4.
    Kumar G, Nilay K, Amit T, Thomas K, Sergey T, Emily M et al (2011) Nationwide trends of severe sepsis in the 21st century (2000–2007). Chest 140:1223–1231PubMedCrossRefGoogle Scholar
  5. 5.
    Zimmerman JE, Andrew AK, William AK (2013) Changes in hospital mortality for United States intensive care unit admissions from 1988 to 2012. Crit Care 17:R81PubMedCrossRefPubMedCentralGoogle Scholar
  6. 6.
    Opal S, Laterre PF, Francois B, LaRosa SP, Angus DC, Mira JP et al (2013) Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA 309:1154–1162PubMedCrossRefGoogle Scholar
  7. 7.
    Guntupalli K, Nathan D, Peter EM, Venkata B, Benjamin M, Emanuel R et al (2013) A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis. Crit Care Med 41:706–716PubMedCrossRefGoogle Scholar
  8. 8.
    Pasin L, Landoni G, Castro ML, Cabrini L, Belletti A, Feltracco P et al (2013) The effect of statins on mortality in septic patients: a meta-analysis of randomized controlled trials. PLoS One 12:e82775CrossRefGoogle Scholar
  9. 9.
    Ranieri VM, Taylor T, Philip SB, Jean-François D, Ivor SD, Simon F et al (2012) Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 366:2055–2064PubMedCrossRefGoogle Scholar
  10. 10.
    Annane D, Timsit JF, Megarbane B, Martin C, Misset B, Mourvillier B et al (2013) Recombinant human activated protein C for adults with septic shock: a randomized controlled trial. Am J Respir Crit Care Med 187:1091–1097PubMedCrossRefGoogle Scholar
  11. 11.
    Crivellari M, Silvetti S, Gerli C, Landoni G, Franco A, Bove T et al (2013) Protein C zymogen in adults with severe sepsis or septic shock. Med Intensiva 38:278–282. doi: 10.1016/j.medin.2013.04.005 PubMedCrossRefGoogle Scholar
  12. 12.
    Crivellari M, Della Valle P, Landoni G, Pappalardo F, Gerli C, Bignami E et al (2009) Human protein C zymogen concentrate in patients with severe sepsis and multiple organ failure after adult cardiac surgery. Intensive Care Med 35:1959–1963PubMedCrossRefGoogle Scholar
  13. 13.
    Klevens RM, Edwards JR, Richards LR Jr, Horan TC, Gaynes RP, Pollock DA et al (2007) Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 122:160–166PubMedPubMedCentralGoogle Scholar
  14. 14.
    Rice LB (2009) The clinical consequences of antimicrobial resistance. Curr Opin Microbiol 12:476–481PubMedCrossRefGoogle Scholar
  15. 15.
    Brunkhorst FM, Oppert M, Marx G, Bloos F, Ludewig K, Putensen C et al (2012) Effect of empirical treatment with moxifloxacin and meropenem vs. meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial. JAMA 307:2390–2399PubMedCrossRefGoogle Scholar
  16. 16.
    Schortgen F, Clabault K, Katsahian S, Devaquet J, Mercat A, Deye N et al (2012) Fever control using external cooling in septic shock: a randomized controlled trial. Am J Respir Crit Care Med 185:1088–1095PubMedCrossRefGoogle Scholar
  17. 17.
    Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S et al (2013) Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA 310:1683–1691PubMedCrossRefGoogle Scholar
  18. 18.
    Vincent J, Rello J, Marshall J (2009) International study of the prevalence and outcomes of infection in intensive care units. JAMA 302:2323–2329PubMedCrossRefGoogle Scholar
  19. 19.
    Ramphal R (2005) Importance of adequate initial antimicrobial therapy. Chemotherapy 51:171–176PubMedCrossRefGoogle Scholar
  20. 20.
    Cohen J, Cristofaro P, Carlet J, Opal S (2004) New method of classifying infections in critically Ill patients. Crit Care Med 32:1510–1526PubMedCrossRefGoogle Scholar
  21. 21.
    Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP (1995) The Natural History of the Systemic Inflammatory Response Syndrome (SIRS). A prospective study. JAMA 273:117–123PubMedCrossRefGoogle Scholar
  22. 22.
    Sundararajan V, Macisaac C, Presneill JJ, Cade JF, Visvanathan K (2005) Epidemiology of sepsis in Victoria, Australia. Crit Care Med 33:71–80PubMedCrossRefGoogle Scholar
  23. 23.
    Eidelman LA, Putterman D, Putterman C, Sprung CL (1966) The spectrum of septic encephalopathy. definitions, etiologies, and mortalities. JAMA 275:470–473CrossRefGoogle Scholar
  24. 24.
    Friedman G, Silva E, Vincent JL (1998) Has the mortality of septic shock changed with time. Crit Care Med 26:2078–2086PubMedCrossRefGoogle Scholar
  25. 25.
    Angus DC, van der Poll T (2013) Severe sepsis and septic shock. NEJM 369:840–851PubMedCrossRefGoogle Scholar
  26. 26.
    Angus DC, Carlet J, 2002 Brussels Roundtable Participants (2003) Surviving intensive care: a report from the 2002 Brussels Roundtable. Intensive Care Med 29:368–377PubMedGoogle Scholar
  27. 27.
    American Thoracic Society (2001) Guidelines for the management of adults with community-acquired pneumonia. http://www.thoracic.org/statements/resources/archive/commacq1-25.pdf. Accessed 19 Feb 2014
  28. 28.
    Reissig A, Copetti R (2014) Lung ultrasound in community-acquired pneumonia and in interstitial lung diseases. Respiration 87:179–189. doi: 10.1159/000357449 PubMedCrossRefGoogle Scholar
  29. 29.
    Reynaldos CM, Györik T, Lora S, Gaia V, Pagnamenta A (2014) ARDS with septic shock due to Legionella longbeachae pneumonia in a patient with polymyalgia rheumatic. Heart Lung Vessel 6:114–118Google Scholar
  30. 30.
    American Thoracic Society, Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171:388–416CrossRefGoogle Scholar
  31. 31.
    Magill SS, Klompas M, Balk R, Burns SM, Deutschman CS, Diekema D et al (2013) Developing a new, national approach to surveillance for ventilator-associated events. Crit Care Med 41:2467–2475PubMedCrossRefGoogle Scholar
  32. 32.
    Cruciani M (2011) Meta-analyses of diagnostic tests in infectious diseases: how helpful are they in the intensive care setting? HSR Proc Intensive Care Cardiovasc Anesth 3:103–108PubMedPubMedCentralGoogle Scholar
  33. 33.
    Lung M, Codina G (2012) Molecular diagnosis in HAP/VAP. Curr Opin Crit Care 18:487–494PubMedCrossRefGoogle Scholar
  34. 34.
    Gattinoni L, Protti A, Caironi P, Carlesso E (2010) Ventilator-induced lung injury: the anatomical and physiological framework. Crit Care Med 38:S539–S548PubMedCrossRefGoogle Scholar
  35. 35.
    Ricard JD, Dreyfuss D, Saumon G (2003) Ventilator-induced lung injury. Eur Respir J 42:2s–9sCrossRefGoogle Scholar
  36. 36.
    Zangrillo A, Biondi-Zoccai G, Landoni G, Frati G, Patroniti N, Pesenti A et al (2013) Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: a systematicreview and meta-analysis including 8 studies and 266 patients receiving ECMO. Crit Care 17:R30PubMedCrossRefPubMedCentralGoogle Scholar
  37. 37.
    Zangrillo A, Landoni G, Biondi-Zoccai G, Greco M, Greco T, Frati G et al (2013) A meta-analysis of complications and mortality of extracorporeal membrane oxygenation. Crit Care Resusc 15:172–178PubMedGoogle Scholar
  38. 38.
    Barbier F, Andremont F, Wolff M, Bouadma L (2013) Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and management. Curr Opin Pulm Med 19:216–228PubMedCrossRefGoogle Scholar
  39. 39.
    Menichetti F, Sganga G (2009) Definition and classification of intra-abdominal infections. J Chemother 21:3–4PubMedCrossRefGoogle Scholar
  40. 40.
    Sartelli M, Viale P, Catena F, Ansaloni L, Moore E, Malangoni M et al (2013) 2013 WSES guidelines for management of intra-abdominal infections. World J Emerg Surg 8:3PubMedCrossRefPubMedCentralGoogle Scholar
  41. 41.
    Marshall JC, Innes M (2008) Intensive care unit management of intra-abdominal infection. Crit Care Med 31:2228–2237CrossRefGoogle Scholar
  42. 42.
    Moran BJ, Heald RJ (2001) Risk factors for, and management of anastomotic leakage in rectal surgery. Colorectal Dis 3:135–137PubMedCrossRefGoogle Scholar
  43. 43.
    De Ruiter J, Weel J, Manusama E, Kingma WP, van der Voort PHJ (2009) The epidemiology of intra-abdominal flora in critically ill patients with secondary and tertiary abdominal sepsis. Infection 37:522–527PubMedCrossRefGoogle Scholar
  44. 44.
    Peake SL, Bailey M, Bellomo R, Cameron PA, Cross A, Delaney A et al (2009) Australasian resuscitation of sepsis evaluation (ARISE): a multi-centre, prospective, inception cohort study. Resuscitation 80:811–818PubMedCrossRefGoogle Scholar
  45. 45.
    Chen Y, Nitzan O, Saliba W, Chazan B, Colodner R, Raz R (2006) Are blood cultures necessary in the management of women with complicated pyelonephritis? J Infect 53:235–240PubMedCrossRefGoogle Scholar
  46. 46.
    Calandra T, Cohen J, International Sepsis Forum Definition of Infection in the ICU Consensus Conference (2005) The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med 33:1538–1548PubMedCrossRefGoogle Scholar
  47. 47.
    Raz R, Schiller D, Nicolle LE (2000) Chronic indwelling catheter replacement before antimicrobial therapy for symptomatic urinary tract infection. J Urol 164:1254–1258PubMedCrossRefGoogle Scholar
  48. 48.
    Nicolle LE (2013) Urinary tract infection. Crit Care Clin 29:699–715PubMedCrossRefGoogle Scholar
  49. 49.
    Grabe M, Bjerklund-Johansen TE, Botto H (2011) Guidelines on urological infections. Eur Assoc of Urology. Available at: http://www.uroweb.org/gls/pdf/18_Urological%20infections_LR.pdf. Accessed 13 Feb 2014
  50. 50.
    Sheu CC, Gong MN, Zhai R, Bajwa EK, Chen F, Thompson TB et al (2010) The influence of infection sites on development and mortality of ARDS. Intensive Care Med 36:963–970PubMedCrossRefPubMedCentralGoogle Scholar
  51. 51.
    Schorr CA, Zanotti S, Dellinger RP (2014) Severe sepsis and septic shock: management and performance improvement. Virulence 5:190–199PubMedCrossRefPubMedCentralGoogle Scholar
  52. 52.
    Townsend SR, Schorr C, Levy MM, Dellinger RP (2008) Reducing mortality in severe sepsis: the surviving sepsis campaign. Clin Chest Med 29:721–733PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Giacomo Monti
    • 1
  • Giovanni Landoni
    • 2
    Email author
  • Daiana Taddeo
    • 1
  • Francesca Isella
    • 1
  • Alberto Zangrillo
    • 2
  1. 1.Department of Anesthesia and Intensive CareIRCCS San Raffaele Scientific InstituteMilanItaly
  2. 2.Department of Anesthesia and Intensive CareIRCCS San Raffaele Scientific Insitute and University Vita-Salute San RaffaeleMilanItaly

Personalised recommendations